| abstract |
The present invention addresses the problem of elucidating a polynucleotide which is a novel causative gene for cancer, and providing, as a result, a method for detecting said polynucleotide or a polypeptide encoded thereby, a primer set therefor, and a detection kit. In the detection method, either a fusion gene comprising a portion of the OCLN gene and a portion of the ARHGAP26 gene, or a fusion protein encoded thereby is detected. The primer set includes: a sense primer designed from the portion encoding OCLN; and an antisense primer designed from the portion encoding ARHGAP26. |